Reach your audience. Get results.
Rely on the experience, guidance, and superior media targeting of Business Wire for your global press release distribution.
![](/images/homepage_main_image.png)
Public RelationsMaximize the reach of your news with our press release distribution services and partnerships. Investor RelationsReach and engage investors, shareholders, analysts, and media with our complete suite of IR services and tools. Distribution & AnalyticsTarget your news, reach your audiences, and understand the impact of your press releases with our analytics reports. |
Latest News
Today is May 23, 2024.
All times in Eastern Daylight Time.
-
OKLAHOMA CITY--(BUSINESS WIRE)--Federman & Sherwood Investigates Association of California School Administrators for Data Breach more »
-
Bristol Myers Squibb to Present Data at ASCO & EHA from More Than 130 Studies Across 25 Diseases Supporting Expansion into New Indications, Demonstrating Long-Term Survival, and Highlighting Novel Modalities and Research PlatformsPRINCETON, N.J.--(BUSINESS WIRE)--Bristol Myers Squibb to Present Data at ASCO & EHA from More Than 130 Studies Across 25 Diseases Supporting Expansion into New Indications.... more »
-
Aulos Bioscience Provides Positive Interim Phase 1/2 Data From AU-007 at 2024 ASCO Annual MeetingLARKSPUR, Calif.--(BUSINESS WIRE)--Aulos Bioscience, an immuno-oncology company working to revolutionize cancer care through the development of best-in-class IL-2 therapeutics, today shared interim... more »
-
TelevisaUnivision Announces Pricing of $1.0 Billion DebtNEW YORK--(BUSINESS WIRE)--TelevisaUnivision, Inc. today announced that its wholly-owned subsidiary, Univision Communications Inc. (the “Company”), has priced its refinancing of $1.0 billion of deb... more »
-
TIGER Study Reports New TTFields Therapy Survival Results for Newly Diagnosed Glioblastoma Patients in GermanyROOT, Switzerland--(BUSINESS WIRE)--Novocure (NASDAQ: NVCR) today released topline efficacy and safety data from the TIGER study investigating the use of Tumor Treating Fields (TTFields) therapy in... more »
-
CAMBRIDGE, England & BOSTON--(BUSINESS WIRE)--Bicycle Therapeutics plc (NASDAQ: BCYC), a pharmaceutical company pioneering a new and differentiated class of therapeutics based on its proprietary bi... more »
-
BNY Mellon Alcentra Global Multi-Strategy Credit Fund, Inc. Declares DistributionNEW YORK--(BUSINESS WIRE)--On May 23, 2024, BNY Mellon Alcentra Global Multi-Strategy Credit Fund, Inc. (Ticker: XALCX) declared a distribution of $2.00 per share of common stock, payable on June 2... more »
-
KBRA Assigns AAA Rating, Stable Outlook to the New Mexico Finance Authority State Transportation Revenue Refunding Bonds (State Transportation Commission - Senior Lien), Series 2024ANEW YORK--(BUSINESS WIRE)--KBRA has assigned a long-term rating of AAA to the New Mexico Finance Authority State Transportation Revenue Refunding Bonds (State Transportation Commission - Senior Lie... more »
-
Stellar Bancorp, Inc. Declares Quarterly Dividend and New Share Repurchase ProgramHOUSTON--(BUSINESS WIRE)--Stellar Bancorp, Inc. (the “Company”) (NYSE: STEL) today announced that on May 23, 2024, its Board of Directors declared a quarterly cash dividend in the amount of $0.13 p... more »
-
Verastem Oncology Announces Positive Initial Interim Safety and Efficacy Results from RAMP 205 Trial Evaluating Avutometinib Plus Defactinib in Combination with Gemcitabine and Nab-paclitaxel in First-Line Metastatic Pancreatic CancerBOSTON--(BUSINESS WIRE)--Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with cancer, today announced the initial interim safety and ... more »
-
MINNEAPOLIS--(BUSINESS WIRE)--NMDPSM, a global nonprofit leader in cell therapy, and the CIBMTR® (Center for International Blood and Marrow Transplant Research®), announced that interim results fro... more »
-
EMD Serono to Showcase Advances in the Science of Cancer With New Data Presented at ASCO 2024ROCKLAND, Mass.--(BUSINESS WIRE)--EMD Serono, the Healthcare business of Merck KGaA, Darmstadt, Germany, in the U.S. and Canada, today announced new research from the company’s diverse oncology por... more »
-
Menarini Group Presents Updated Data from ELECTRA and ELEVATE Combination Studies of Elacestrant (ORSERDU®) in Patients with ER+, HER2- Metastatic Breast Cancer (mBC) at the ASCO 2024 Annual MeetingFLORENCE, Italy & NEW YORK--(BUSINESS WIRE)--The Menarini Group (“Menarini”), a leading international pharmaceutical and diagnostics company, and Stemline Therapeutics, Inc. (“Stemline”), a wholly-... more »
-
Dentalcorp Announces Annual General Meeting Voting ResultsTORONTO--(BUSINESS WIRE)--Dentalcorp Holdings Ltd. ("Dentalcorp" or the "Company"), (TSX: DNTL) Canada’s largest and one of North America's fastest growing networks of dental practices, announced t... more »
-
AffyImmune Announces Confirmed Complete Response in Patient with Anaplastic Thyroid CancerNATICK, Mass.--(BUSINESS WIRE)--AffyImmune Announces Confirmed Complete Response in Patient with Anaplastic Thyroid Cancer more »